Zymeworks ZYME Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $244.28M+221% | $41.16M-37.7% | $64.83M-47.0% | $98.25M+38.5% | $76.2M-33.6% | ||
| $41.3M-69.7% | $61.22M-57.1% | $112.39M+5.8% | $106.74M-28.7% | $136.19M-18.2% | ||
| $385.68M+25.8% | $248.77M-17.2% | $291.71M-15.1% | $296.13M-22.8% | $306.47M-22.2% | ||
| $14.85M-11.0% | $15.5M-12.2% | $15.82M-13.7% | $16.31M-11.7% | $16.69M-12.1% | ||
| $12.02M0.0% | $12.02M0.0% | $12.02M0.0% | $12.02M0.0% | $12.02M0.0% | ||
| $1.17M-65.1% | $1.35M-70.5% | $1.4M-78.2% | $2.05M-71.2% | $3.36M-54.7% | ||
| $39.12M-30.6% | $41.79M-57.5% | $47.43M-38.9% | $52M— | $56.32M— | ||
| $478.22M+12.4% | $346.53M-25.2% | $397.27M-18.5% | $408.39M-20.8% | $425.52M-23.2% | ||
| $30.23M+479% | $36.35M+831% | $1.31M-61.9% | $32K-98.2% | $5.22M+107% | ||
| $2.08M-91.2% | $2.42M-90.6% | $3.2M-88.2% | $3.81M-31.0% | $23.5M+583% | ||
| $35.65M-45.2% | $42.32M-52.1% | $42.04M-49.9% | $38.5M-29.6% | $65.1M+14.4% | ||
| $314.63M+213% | $78.03M-37.2% | $77.21M-35.8% | $73.88M-32.5% | $100.56M-13.1% | ||
| 900M0.0% | 900M-11.4% | 900M0.0% | 900M0.0% | 900M0.0% | ||
| -$1.07B-25.9% | -$953.16M-14.8% | -$886.47M-11.1% | -$850.65M-13.9% | -$852.97M-20.3% | ||
| $163.59M-49.7% | $268.5M-20.7% | $320.06M-12.8% | $334.51M-17.6% | $324.97M-25.8% | ||
| $478.22M+12.4% | $346.53M-25.2% | $397.27M-18.5% | $408.39M-20.8% | $425.52M-23.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Zymeworks cover its short-term obligations?
- Its current ratio is 10.82 — current assets exceed current liabilities.
- Where does Zymeworks's balance sheet data come from?
- Every line is extracted from Zymeworks's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.